FDA Drug information
Erlotinib Hydrochloride
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- ERLOTINIB HYDROCHLORIDE ERLOTINIB HYDROCHLORIDE 100 mg/1 Alembic Pharmaceuticals Inc.
- ERLOTINIB HYDROCHLORIDE ERLOTINIB HYDROCHLORIDE 100 mg/1 Alembic Pharmaceuticals Limited
- Erlotinib Hydrochloride ERLOTINIB HYDROCHLORIDE 100 mg/1 Novadoz Pharmaceuticals LLC
- ERLOTINIB HYDROCHLORIDE ERLOTINIB HYDROCHLORIDE 150 mg/1 Alembic Pharmaceuticals Inc.
- ERLOTINIB HYDROCHLORIDE ERLOTINIB HYDROCHLORIDE 150 mg/1 Alembic Pharmaceuticals Limited
- Erlotinib Hydrochloride ERLOTINIB HYDROCHLORIDE 150 mg/1 Novadoz Pharmaceuticals LLC
- ERLOTINIB HYDROCHLORIDE ERLOTINIB HYDROCHLORIDE 25 mg/1 Alembic Pharmaceuticals Inc.
- ERLOTINIB HYDROCHLORIDE ERLOTINIB HYDROCHLORIDE 25 mg/1 Alembic Pharmaceuticals Limited
- Erlotinib Hydrochloride ERLOTINIB HYDROCHLORIDE 25 mg/1 Novadoz Pharmaceuticals LLC
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.